Zometa 4 mg/100 ml solution for infusion

DRUG3 trials

Sponsors

Institut De Cancerologie De L Ouest, Unicancer, Pauls Stradins Clinical University Hospital

Conditions

GlioblastomaHigh grade osteosarcomaPatientsmen or women over 18 oldwith inoperable vertebral bone metastases who must beneficit treatment with stereotactic radiotherapy

Phase 2

A prospective randomized open-label phase II clinical study evaluating the efficacy and safety of zoledronic acid addition to standard therapy in patients with glioblastoma

RecruitingCTIS2024-519446-67-00

Pauls Stradins Clinical University HospitalGlioblastoma

Start: 2025-03-06Target: 80Updated: 2025-02-28

Phase 3

Multicentre, randomized, controlled, open-label, multi-centre medicoeconomic study evaluating the efficacy of adding zoledronic acid or denosumab to Stereotaxic radiotherapy in the treatment of vertebral metastases (ZOSTER)

RecruitingCTIS2024-513248-27-00

Institut De Cancerologie De L Ouestmen or women over 18 old, Patients, with inoperable vertebral bone metastases who must beneficit treatment with stereotactic radiotherapy

Start: 2020-07-20Target: 202Updated: 2025-08-22

SARCOME 09_Intergroup Study (SFCE/GSF-GETO) OS2006 - Zoledronate Osteosarcoma Treatment Protocol for osteosarcoma of the child, adolescent and adult including: - A randomized trial - And biological studies.

Active, not recruitingCTIS2024-514756-32-00

UnicancerHigh grade osteosarcoma

Start: 2007-03-19Target: 653Updated: 2024-08-12